4.222
전일 마감가:
$4.365
열려 있는:
$4.34
하루 거래량:
38,925
Relative Volume:
0.05
시가총액:
$262.75M
수익:
-
순이익/손실:
$-73.79M
주가수익비율:
-2.2946
EPS:
-1.84
순현금흐름:
$-77.44M
1주 성능:
-17.92%
1개월 성능:
+8.96%
6개월 성능:
+243.56%
1년 성능:
+150.60%
Pyxis Oncology Inc Stock (PYXS) Company Profile
명칭
Pyxis Oncology Inc
전화
(617) 221-9059
주소
321 HARRISON AVENUE, BOSTON
PYXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PYXS
Pyxis Oncology Inc
|
4.22 | 268.98M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.60 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
731.09 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.00 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
913.29 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.21 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 재개 | Stifel | Buy |
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2024-11-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-08-08 | 개시 | Stifel | Buy |
| 2024-05-07 | 재개 | Jefferies | Buy |
| 2024-02-09 | 개시 | BTIG Research | Buy |
| 2024-01-23 | 개시 | Leerink Partners | Outperform |
| 2023-09-05 | 개시 | RBC Capital Mkts | Outperform |
| 2021-11-02 | 개시 | BofA Securities | Neutral |
| 2021-11-02 | 개시 | Credit Suisse | Outperform |
| 2021-11-02 | 개시 | Jefferies | Buy |
모두보기
Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스
Will Pyxis Oncology Inc. stock reach Wall Street targetsPortfolio Value Report & Risk Controlled Daily Trade Plans - Newser
Its Stock Has Paid Off Big Time For Pyxis Oncology Inc - Setenews
Leerink Partnrs Weighs in on Pyxis Oncology FY2025 Earnings - MarketBeat
Pyxis Oncology Keeps Losses Steady As It Eyes Key Trial Data - Finimize
Leerink Partnrs Lowers Earnings Estimates for Pyxis Oncology - Defense World
Pyxis Oncology Files $350 Million Mixed Shelf - marketscreener.com
Pyxis Oncology: MICVO Data Could Be The Tipping Point In 2025 - RTTNews
What drives Pyxis Oncology Inc stock priceStock Screening Results & Free Real-Time Trading Signals - earlytimes.in
Stephens Reaffirms Their Buy Rating on Pyxis Oncology (PYXS) - The Globe and Mail
Stephens & Co. Maintains Pyxis Oncology (PYXS) Overweight Recommendation - Nasdaq
Stephens raises Pyxis Oncology stock price target to $8 on MICVO potential - Investing.com Nigeria
Ready to Jump After Recent Trade: Pyxis Oncology Inc (PYXS) - Setenews
Can Pyxis Oncology Inc. stock weather global recessionSell Signal & Weekly Return Optimization Plans - newser.com
Is Pyxis Oncology Inc. stock vulnerable to regulatory risksPortfolio Value Report & Weekly Momentum Picks - newser.com
What makes Pyxis Oncology Inc. stock attractive to growth funds2025 Market Outlook & Growth Focused Investment Plans - newser.com
Signal strength of Pyxis Oncology Inc. stock in tech scanners - newser.com
Tick level data insight on Pyxis Oncology Inc. volatilityJuly 2025 Decliners & Capital Efficient Trade Techniques - newser.com
Is Pyxis Oncology Inc. stock a bargain at current levels2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
Applying Elliott Wave Theory to Pyxis Oncology Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Can trapped investors hope for a rebound in Pyxis Oncology Inc.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Pyxis Oncology Reports Increased Losses Amid Development Focus - TipRanks
Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - Setenews
How to manage a losing position in Pyxis Oncology Inc.July 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Is Pyxis Oncology Inc. stock gaining market shareJobs Report & Verified Chart Pattern Signals - newser.com
Is Pyxis Oncology Inc. stock cheap at current valuationJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Pyxis Oncology (PYXS) Price Target Increased by 13.33% to 6.94 - Nasdaq
Ranking Pyxis Oncology Inc. among high performing stocks via toolsQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
What Fibonacci levels say about Pyxis Oncology Inc. reboundMarket Growth Summary & Stock Portfolio Risk Control - newser.com
Backtesting results for Pyxis Oncology Inc. trading strategiesMarket Sentiment Review & Growth Focused Investment Plans - newser.com
Published on: 2025-11-16 11:45:49 - newser.com
Will Pyxis Oncology Inc. stock continue upward momentumDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Can Pyxis Oncology Inc. stock beat analyst upgradesIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com
Brokerages Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $7.25 - Defense World
Will Pyxis Oncology Inc. stock see insider buyingStop Loss & Weekly Watchlist for Hot Stocks - Fundação Cultural do Pará
Stifel Nicolaus Remains a Buy on Pyxis Oncology (PYXS) - The Globe and Mail
Will Pyxis Oncology Inc. stock deliver better than expected guidancePortfolio Risk Summary & Verified Entry Point Signals - newser.com
Pyxis Oncology Inc (PYXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):